Am J Gastroenterol
- PAIK JM, Duong S, Zelber-Sagi S, Lazarus JV, et al
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk
of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents
in the United States.
Am J Gastroenterol. 2024;119:1089-1101.
- THABUT D, Rudler M, Weiss N
Diagnosis of Overt Hepatic Encephalopathy With a New Algorithm: Follow-up Data
Are Required.
Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002856.
Anticancer Res
- FUKUSHIMA NM, Adachi T, Tanaka T, Matsushima H, et al
DCLK1 Expression and its Functional Significance in Intrahepatic
Cholangiocarcinoma and Bil-IN Stage.
Anticancer Res. 2024;44:2417-2424.
- IGARASHI Y, Haruki K, Furukawa K, Taniai T, et al
Short-term Outcomes of Laparoscopic Versus Open Liver Resection in the Elderly: A
Propensity Score-matched Analysis.
Anticancer Res. 2024;44:2731-2736.
- TOREN W, Sasor A, Ansari D, Andersson R, et al
ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical
Resection.
Anticancer Res. 2024;44:2597-2604.
Biochem Biophys Res Commun
- ZHU J, Liu Q, Nie S, Huang Y, et al
LEPR/FOS/JUNB signaling pathway contributes to chronic restraint stress-induced
tumor proliferation.
Biochem Biophys Res Commun. 2024;719:150042.
- SUN T, Li S, Li X, Lei Y, et al
Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1alpha mediated
oxidative stress.
Biochem Biophys Res Commun. 2024;721:150130.
- TOMIOKA I, Ota C, Tanahashi Y, Ikegami K, et al
Loss of the DNA-binding domain of the farnesoid X receptor gene causes severe
liver and kidney injuries.
Biochem Biophys Res Commun. 2024;721:150125.
- LI J, Wen W, Li J, Liu T, et al
CNOT7 regulates lipid deposition in nonalcoholic fatty liver disease.
Biochem Biophys Res Commun. 2024;721:150003.
BMC Cancer
- CAO F, Zheng J, Hao W
Combined image-guided radiofrequency and iodine-125 seeds implantation in the
treatment of recurrent hepatocellular carcinoma after hepatectomy.
BMC Cancer. 2024;24:666.
- ZOU W, Fang Z, Feng Y, Gong S, et al
Transcriptomic and genomic characteristics of intrahepatic metastases of primary
liver cancer.
BMC Cancer. 2024;24:672.
- SONG M, Cheng H, Zou H, Ma K, et al
Genomic profiling informs therapies and prognosis for patients with
hepatocellular carcinoma in clinical practice.
BMC Cancer. 2024;24:673.
- YE J, Ying J, Chen H, Wu Z, et al
PPIH acts as a potential predictive biomarker for patients with common solid
tumors.
BMC Cancer. 2024;24:681.
- ZHU Y, Lu F
Astragaloside IV inhibits cell viability and glycolysis of hepatocellular
carcinoma by regulating KAT2A-mediated succinylation of PGAM1.
BMC Cancer. 2024;24:682.
- ALMOHAID S, Akhtar S
Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a
middle eastern country: a case-control study.
BMC Cancer. 2024;24:694.
BMC Gastroenterol
- JAFREE SR, Naveed A, Ahsan H, Burhan SK, et al
Mental health and quality of life in patients with chronic liver disease: a
single-center structural equation model.
BMC Gastroenterol. 2024;24:193.
Clin Res Hepatol Gastroenterol
- L'HUILLIER R, Michoud C, Dumortier J, Milot L, et al
Massive peritoneal tumoral dissemination after hepatocellular carcinoma
percutaneous microwave ablation with intraperitoneal CO(2) insufflation.
Clin Res Hepatol Gastroenterol. 2024;48:102376.
- ROGALSKI J, Czarnecka-Chrebelska K, Weglewska K, Pleska K, et al
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric
inpatients.
Clin Res Hepatol Gastroenterol. 2024;48:102366.
- ZHOU J, Liang T, Xing F, Li X, et al
Probabilistic Scatter Plots for visualizing carbohydrate and lipid metabolism
states in Non-Alcoholic Fatty Liver Disease.
Clin Res Hepatol Gastroenterol. 2024;48:102365.
- ZHAO G, Shi R, Ma M, Lin H, et al
Elevated LDL-c may warn of the risk of gallbladder stones in the patients with
metabolic dysfunction-associated steatotic liver disease: A case-control study.
Clin Res Hepatol Gastroenterol. 2024;48:102363.
- MAREY MM, Belal M, Awad AA, Rabea EM, et al
Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic
review and meta-analysis of randomized controlled trials.
Clin Res Hepatol Gastroenterol. 2024;48:102357.
- LEIDECK P, Nkontchou G, Elkrief L, Erard D, et al
The role and evolution of partial splenic embolization over three decades: A
multicentric retrospective single cohort study of 90 patients from French
nationwide experience.
Clin Res Hepatol Gastroenterol. 2024;48:102355.
- TANAKA A, Corpechot C
PPAR agonists in PBC: Where do we go from here? Or how to choose between the new
and the old.
Clin Res Hepatol Gastroenterol. 2024;48:102358.
- ZHOU F, Liu X, Chang C, Liu J, et al
Separating the effects of early and later life body mass index on liver diseases:
A Mendelian randomization study.
Clin Res Hepatol Gastroenterol. 2024;48:102352.
- BOEKEN T
Redefining challenging liver thermal ablation cases: Present realities, future
prospects.
Clin Res Hepatol Gastroenterol. 2024;48:102342.
- MENG X, Wang L, Du YC, Cheng D, et al
PPARbeta/delta as a promising molecular drug target for liver diseases: A focused
review.
Clin Res Hepatol Gastroenterol. 2024;48:102343.
- PAN X, Hu E, Zhou Y, Li L, et al
The prognostic nutritional index as a predictor of efficacy and early recurrence
for adjuvant transarterial chemoembolization in hepatocellular carcinoma.
Clin Res Hepatol Gastroenterol. 2024;48:102344.
Dig Dis Sci
- SHIH HW, Lai Y, Hung HC, Lee JC, et al
Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple
Tumors Based on Total Tumor Volume.
Dig Dis Sci. 2024 Jun 1. doi: 10.1007/s10620-024-08500.
- FULLER SR, Schreiner AD
Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges.
Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08498.
Eur Radiol
- PICKHARDT PJ, Blake GM, Moeller A, Garrett JW, et al
Post-contrast CT liver attenuation alone is superior to the liver-spleen
difference for identifying moderate hepatic steatosis.
Eur Radiol. 2024 Jun 4. doi: 10.1007/s00330-024-10816.
Gut
- CHEN A, Zhang VX, Zhang Q, Sze KM, et al
Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and
potentiates immune response in hepatocellular carcinoma.
Gut. 2024 Jun 5:gutjnl-2024-331903. doi: 10.1136/gutjnl-2024-331903.
- NISCHALKE HD, Nischalke C, Schmalz F, Moller C, et al
Catecholamines and inflammation in advanced liver disease: more closely
intertwined than expected?
Gut. 2024;73:1219-1222.
- BU L, Zhang Z, Chen J, Fan Y, et al
High-fat diet promotes liver tumorigenesis via palmitoylation and activation of
AKT.
Gut. 2024;73:1156-1168.
Hepatology
- WIGG AJ, Narayana S, Woodman RJ, Adams LA, et al
A randomized multicenter trial of a chronic disease management intervention for
decompensated cirrhosis. The Australian Liver Failure (ALFIE) trial.
Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000862.
J Clin Oncol
- ETTRICH TJ, Modest DP, Sinn M, Striefler JK, et al
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus
Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO
Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
J Clin Oncol. 2024 Jun 6:JCO2301566. doi: 10.1200/JCO.23.01566.
J Gastroenterol Hepatol
- WURSTLE S, Schneider T, Karapetyan S, Hapfelmeier A, et al
LINAS-Score: prognostic model for mortality assessment in patients with cirrhotic
liver and infected ascites.
J Gastroenterol Hepatol. 2024 Jun 5. doi: 10.1111/jgh.16637.
J Hepatol
- PATERNOSTRO R, Kwanten WJ, Hofer BS, Semmler G, et al
Hepatic venous pressure gradient predicts risk of hepatic decompensation and
liver-related mortality in patients with MASLD.
J Hepatol. 2024 May 30:S0168-8278(24)00368-4. doi: 10.1016/j.jhep.2024.
- LAO Y, Cui X, Xu Z, Yan H, et al
Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor
microenvironment in hepatocellular carcinoma.
J Hepatol. 2024 May 31:S0168-8278(24)00369-6. doi: 10.1016/j.jhep.2024.
PLoS One
- HUANG X, Gu H, Shen P, Zhang X, et al
Systematic review and meta-analysis: Evaluating the influence of intrahepatic
cholestasis of pregnancy on obstetric and neonatal outcomes.
PLoS One. 2024;19:e0304604.
Semin Liver Dis
- LIU H, Sethi V, Li X, Xiao Y, et al
Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative
Review and A Glimpse into The Future.
Semin Liver Dis. 2024;44:e1-e3.
Transplantation
- WEHRLE CJ, Kusakabe J, Akabane M, Maspero M, et al
Expanding Selection Criteria in Deceased Donor Liver Transplantation for
Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2
Transplant Centers.
Transplantation. 2024 Jun 4. doi: 10.1097/TP.0000000000005097.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016